Gilead Sciences, Inc.
Multispecific antibodies that target HIV GP120 and CD3

Last updated:

Abstract:

Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.

Status:
Grant
Type:

Utility

Filling date:

21 Jun 2018

Issue date:

5 Jan 2021